drugset
drugset / Trial / NCT03345550

OPTIMA-TBI Pilot Study

NCT03345550 ↗

Phase 2 Terminated 44 enrolled University of Michigan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a double-blind, randomized controlled trial comparing the effect of omega-3 fatty acid versus placebo on blood biomarkers of brain injury, inflammation and neurogenesis.

Timeline

Start
2017-09-12
Primary completion
2021-07-27
Completion
2021-07-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3 fatty acids Unknown 1.2 g —

Indications

traumatic brain injury